drugset / Trial / NCT05389150

Non-interaction Study Between Pregabalin and Tramadol, Administered Individually or Combination, in Healthy Subjects

NCT05389150

Phase 1 Completed 30 enrolled Laboratorios Silanes S.A. de C.V.
RandomizedCrossoverOpen-labelTreatment

Summary

The study was carried out in the Clinical Unit and Analytical Unit of the Department of Pharmacology and Toxicology of the Faculty of Medicine of the Universidad Autónoma de Nuevo León, with the aim of comparing the bioavailability (maximum concentration and area under the curve) of an oral formulation containing Pregabalin 150 mg/Tramadol 50 mg in combination with the two oral formulations Pregabalin 150 mg or Tramadol 50 mg administered as a single dose, in healthy subjects under fasting conditions.

Timeline

Start
2019-01-17
Primary completion
2019-02-05
Completion
2019-03-27

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pregabalin Small molecule 150 mg Oral
Comparator Tramadol Other / unclassified 50 mg Oral

Indications

No indication recorded.